FDA says its drug approval rate is unchanged But what s entering the market?
Perhaps responding to ACSH’s Director of Chemical and Pharmaceutical Sciences Dr. Josh Bloom’s op-ed on the effect of the FDA’s overly-precautionary regulations on the pharmaceutical industry, the FDA is countering claims that it is not approving enough drugs. The agency published a statement arguing that the number of approvals for novel drugs, called new molecular entities (NMEs), has remained stable over the past decade.
